{"url_path":"/sec/ctnm/8-k/2026-07-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-13","source_url":"https://www.sec.gov/Archives/edgar/data/1855175/0001628280-26-048023-index.html","accession_number":"0001628280-26-048023","cik":"0001855175","ticker":"CTNM","issuer_name":"Contineum Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855175/0001628280-26-048023-index.html","primary_entity_key":"0001855175","primary_entity_name":"Contineum Therapeutics, Inc."},"word_count":84,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.Description\n\n99.1\n[Corporate Presentation of Contineum Therapeutics, Inc.](ctnmcorporatepresentatio.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: July 13, 2026\n\nContineum Therapeutics, Inc.\n\nBy: /s/ Peter Slover\n\nPeter Slover\n\nChief Financial Officer\n\nPrincipal Financial Officer and Principal Accounting Officer"}